Classys’ Medical Aesthetics Business Model

The global medical aesthetics market continues to evolve as providers increasingly adopt non-invasive treatments that deliver natural-looking results with minimal downtime. Specifically, energy-based devices (EBDs) are becoming an increasingly important part of aesthetic practices, and companies like Classys are demonstrating why.

A Recurring Revenue Model for Medical Aesthetics

Unlike traditional medical device companies that rely primarily on equipment sales, the Classys business model is built around long-term device utilization. Once a platform is installed in a practice, providers continue purchasing consumables such as cartridges and treatment tips, creating recurring revenue beyond the initial device sale.
According to the company’s latest annual report, consumables represented 46% of total revenue in 2025, highlighting the strength of a platform-based business model.

Growing Demand for Energy-Based Devices

Demand for non-invasive aesthetic procedures continues to increase as patients seek treatments that improve skin quality without surgery or lengthy recovery times. Energy-based technologies such as high-intensity focused ultrasound (HIFU) are becoming popular options for skin tightening and facial rejuvenation.
Classys reported that more than 5.5 million Ultraformer HIFU procedures were performed worldwide in 2025, reflecting growing global adoption of these technologies.

Scaling Through Global Expansion

Classys now operates in more than 80 countries with an installed base exceeding 45,000 aesthetic platforms, giving providers access to its technology across a broad global network. The company projects approximately 45% year-over-year revenue growth, supported by continued demand for both devices and consumables.

The Future of Medical Aesthetics

As the medical aesthetics industry shifts toward non-invasive treatments, companies with scalable platforms and recurring revenue models are well positioned for long-term growth. Classys’ combination of energy-based devices, consumable-driven revenue, and global expansion illustrates how innovation extends beyond technology itself to include sustainable business strategies.
With increasing demand for minimally invasive procedures and continued investment in aesthetic technology, platform-based models may play an increasingly important role in shaping the future of medical aesthetics.

Source: https://www.medestheticsmag.com/home/article/22965538/inside-classys-highgrowth-highmargin-aesthetics-model